Biosimilars Market Size

The global biosimilar market is projected to surge from $25.1 billion in 2022 to approximately $1.3 trillion by 2032, with a compound annual ...

The global biosimilars market size was USD 29.45 billion in 2023, calculated at USD 34.66 billion in 2024 and is expected to reach around USD 150.26 billion by ...

The global biosimilar market was approximately generating $27.3 billion in 2023, with this number projected to reach $92 billion by 2031.

The global biosimilars market size was valued at $20.44 billion in 2022 & is projected to grow from $23.96 billion in 2023 to $73.03 billion by 2030.

Biosimilars market growth is primed to transition from 29.4 billion in 2023 to USD 66.9 billion by 2028, showcasing a strong CAGR of 17.8%.

The global biosimilars market size was valued at USD 21.8 billion in 2022 and is expected to grow at a CAGR of 15.9% over the forecast period.

An inflection point for biosimilars - McKinsey & Company

According to McKinsey's biosimilars market model, the market is set to continue its double-digit growth, doubling in size to more than $30 ...

The U.S. biosimilars market is projected to grow from $9.48 billion in 2022 to $100.75 billion by 2029, at a CAGR of 40.2% in forecast period, 2022-2029.

The global biosimilars market size is estimated to grow from $24.2 billion in 2024 to $130.1 billion by 2035, at a CAGR of 16.5% during the forecast period, ...

The biosimilars market size was worth more than USD 35 billion in 2022 and is poised to witness substantial growth at 13% CAGR from 2023 to 2032 driven by ...

The global biosimilar market size reached USD 21.2 Billion in 2023 and expected to reach USD 164.5 Billion by 2032, at a CAGR of 25.1%.

Biosimilars Market Size & Growth Analysis: ... The Biosimilars Market Size was valued at USD 29.51 Billion in 2023 and is expected to reach USD 127.92 Billion By ...

The Global Biosimilars Market is expected to reach USD 35.47 billion in 2024 and grow at a CAGR of 18.32% to reach USD 82.27 billion by 2029.

Global Biosimilars Market is expected to rise from USD 27.30 bn to reach a value of USD 92 Bn by 2031, at a CAGR of 16.4% over the forecast period ...

The Biosimilars market is projected to grow from USD 35.14 Billion in 2022 to USD 216.32 Billion by 2030, at a CAGR of 25.50% during the forecast period.

Biosimilar and Biologics Market Outlook from 2024 to 2034. The global biosimilar & biologics market size is expected to expand from US$ 520.9 billion in 2024 to ...

Biosimilars Market size was valued at USD 27.11 billion in 2024 and is expected to exceed USD 415.92 billion by the end of 2037, registering ...

The global biosimilars market size is expected to surpass around USD 126.01 billion by 2032 from USD 29.39 billion with a CAGR of 17.6% from 2023 to 2032.

In Pegfilgrastim and Epoetin alfa, the reference products match biosimilars' ASP in an effort to retain market share. However, Neupogen maintains higher ASP ...

Three imperatives for R&D in biosimilars - McKinsey & Company

The US market has seen the fastest growth in biosimilars, with a CAGR of 97 percent from 2015 to 2021, compared with 48 percent in Europe and 39 ...

Biosimilars Market Size

Acertus Pharma Pte ltd